Led by Brown Medical School professor and Rhode Island Hospital investigator Eduardo Nillni, the team found that PC1 and PC2 chop up the precursor of thyrotropin-releasing hormone (TRH), a process that sets the molecules in motion. The smaller TRH peptides go on, through a complex chemical cascade, to stimulate the pituitary gland and the thyroid.
The end result: Food intake is inhibited. The body burns more calories.
PC1 and PC2 perform their crucial protein-cutting function not only on the chemical forerunner of TRH, but on several metabolic brain messengers, researchers say. These include insulin, the hormone that controls blood sugar. This finding will aid in the understanding and treatment of obesity, which affects nearly 68 million adults, teen-agers and children in the United States.
"What we have is an important discovery of how leptin regulates specific enzymes," Nillni said. "While scientists have known for about a decade that PC1 and PC2 play a role in peptide processing, we did not know their importance in activating neuropeptides so key to energy balance. It's a thrilling finding."
The National Institutes of Health funded the research in Nillni's laboratory. It was conducted at Brown Medical School and Rhode Island Hospital in Providence and Harvard Medical School and Beth Israel Deaconess Medical Center in Boston.
Results are published in the current issue of The Journal of Clinical Investigation.
Nillni and many other endocrinologists are intensely interested in leptin, a hormone produced in fat tissue and a key player in eating and energy use.
Nillni and the team found that when leptin moves through the
'"/>
Contact: Wendy Lawton
Wendy_Lawton@brown.edu
401-863-1862
Brown University
2-Aug-2004